Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
Holding VRCA?
Track your performance easily

Verrica Pharmaceuticals (VRCA) Financial Statements

312 Followers

Verrica Pharmaceuticals Financial Overview

Verrica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.746; its P/E ratio is -4.88; Verrica Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 3.83M$ 1.99M$ 2.92M$ 182.00K$ 37.00K
Gross Profit$ 3.83M$ 1.99M$ 2.92M$ 182.00K$ 37.00K
EBIT$ -16.87M-$ -22.61M$ -10.72M$ -7.09M
EBITDA$ -16.56M--$ -10.51M$ -6.89M
Net Income Common Stockholders$ -19.19M$ -24.61M$ -24.26M$ -10.99M$ -6.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 48.90M$ 69.50M$ 84.30M$ 55.10M$ 60.00M
Total Assets$ 66.31M$ 81.60M$ 97.15M$ 62.16M$ 68.64M
Total Debt$ 46.44M$ 45.51M$ 43.82M$ 1.38M$ 1.45M
Net Debt$ -2.46M$ -23.99M$ -40.48M$ -53.72M$ -58.55M
Total Liabilities$ 64.80M$ 61.83M$ 54.84M$ 6.80M$ 3.79M
Stockholders Equity$ 1.51M$ 19.76M$ 42.30M$ 55.43M$ 64.85M
Cash Flow-
Free Cash Flow$ -19.95M--$ -4.73M$ -4.60M
Operating Cash Flow$ -19.95M$ -14.51M$ -14.81M$ -4.67M$ -4.59M
Investing Cash Flow-$ -227.00K$ -65.00K$ -59.00K$ -11.00K
Financing Cash Flow$ -661.00K$ -27.00K$ 44.04M$ -84.00K$ 30.28M
Currency in USD

Verrica Pharmaceuticals Earnings and Revenue History

Verrica Pharmaceuticals Debt to Assets

Verrica Pharmaceuticals Cash Flow

Verrica Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis